Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FX3P2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,018
Award facts
- Contract value 100% obligated
- $35,017.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $35,017.65. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis with nasal polyps, making it a critical specialty pharmaceutical for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle providing a wide range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established role as a major pharmaceutical distributor and its successful competitive track record with the Defense Logistics Agency demonstrate the company's capability to meet federal procurement requirements for specialized medical products supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FX3P2?
SPE2DR26FX3P2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FX3P2 worth?
The government has obligated $35,018 on SPE2DR26FX3P2.
Is contract SPE2DR26FX3P2 an order under another contract?
Yes. SPE2DR26FX3P2 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX3P2 competed?
The extent of competition for SPE2DR26FX3P2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award